28 research outputs found
Acute fibrinous and organizing pneumonia associated with influenza A/H1N1 pneumonia after lung transplantation
Full text linkInfluenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.
Get PDFImmunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination is widely recommended for this group. This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in terms of preventing influenza-like illness and laboratory confirmed influenza, serological response and adverse events
Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication
No full textDonor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee
No full textInternational consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Full text linkCytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues
Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients
No full textCytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
No full textThe CMV Symposium in September 2021 was an international conference dedicated to cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell transplantation. This review provides an overview of the presentations given by the expert faculty, supplemented with educational clinical cases. Topics discussed include CMV epidemiology and diagnosis, the burden of CMV infection and disease, CMV-specific immunity and management of CMV in transplant settings. Major advances in the prevention and treatment of CMV in the past decade and increased understanding of CMV immunity have led to improved patient outcomes. In the future, management algorithms may be individualized based on the transplant recipient's immune profile, which will mark the start of a new era for patients with CMV
